BUZ INVESTORS Virtual Reality Studio Facebook Inc. (FB) is shutting down the Oculus Story Studio, its in-house studio launched two years ago to produce virtual reality content for the Oculus VR headset.

Facebook to test subscription news product in fall

Facebook to test subscription news product in fall

BUZ INVESTORS Virtual Reality Studio Facebook Inc. <span data-recalc-dims=(FB) is shutting down the Oculus Story Studio, its in-house studio launched two years ago to produce virtual reality content for the Oculus VR headset." width="300" height="216" srcset="https://i1.wp.com/investorsbuz.com/wp-content/uploads/2017/05/facebook-oculus-050517-Small.jpg?resize=300%2C216 300w, https://i1.wp.com/investorsbuz.com/wp-content/uploads/2017/05/facebook-oculus-050517-Small.jpg?w=668 668w" sizes="(max-width: 300px) 100vw, 300px" />

INVESTORS  subscription news Facebook (FB+1.4%) is setting up a subscription-based news product that it will start testing in October, the company’s Campbell Brown told the Digital Publishing Innovation Summit.

The product looks to be built on its Instant Articles and would call for setting up a paywall requiring readers to subscribe after reading 10 articles. It would also still steer readers to publication home pages to promote digital subscriptions directly to the publishers.



 subscription news

 

 

“One of the things we heard in our initial meetings from many newspapers and digital publishers is that ‘We want a subscription product — we want to be able to see a paywall in Facebook,’ ” Brown said, without elaborating on whether/how Facebook would share payments for its paywall.

Facebook shares are at an all-time high today of $165.25.

Like up on FACEBOOK


logo

Market quotes are powered by
TradingView.com



Tech Stocks ( GOOG)   (MSFT ) ( AAPL ) (BBRY ) ( gopro )  ( WDC )



BUZ INVESTORS Market Open U.S. missile attack on Syria puts markets on edge. The order of the missile attack on Syria

Top News Before the Market Opens

Top News Before the Market Opens

BUZ INVESTORS Market Open U.S. missile attack on Syria puts markets on edge. The order of the missile attack on Syria

BUZ INVESTORS Top News   Tesla will deliver the first 30 Model 3s on July 28th. Tesla will start delivering its much-anticipated Model 3 EV this month, as promised. CEO Elon Musk tweeted that the company will have a “handover party for [the] first 30 customer Model 3s on the 28th.” He added that production will grow exponentially, “so August should be 100 cars and September above 1,500.” By December, the company will be building 20,000 cars per month, he said in a subsequent tweet. The goal is to produce up to 10,000 cars per week by 2018. Read more here.





 


  • Verizon rumored to be eyeing purchase of Disney. “One rumor making the rounds last week was that Verizon may be eyeing a Disney purchase. While that sounds fantastical, a well-placed banker told On the Money not to count Verizon out.” On the Money is a section of the New York Post. Verizon already snapped up assets of AOL and Yahoo to keep up with AT&T, which recently purchased Time Warner. Read more here.

  • Caterpillar faces new questions in probe. WSJ reports that federal investigators believe Caterpillar failed to submit numerous required export filings with the government in recent years, adding to the regulatory questions facing the manufacturing giant. The findings are preliminary, but offer an avenue for investigators to examine whether missing export submissions were part of a possible effort by Caterpillar to avoid paying taxes. Read more here.

  • Eurozone manufacturing at six-year high. Following the positive data out from China, factories in the euro area closed out the second quarter with their fastest rate of activity in 6 years while job creation remained near May’s record high. IHS Markit’s manufacturing PMI for the euro zone rose to 57.4 in June, up from May’s 57.0 and pipping the preliminary reading of 57.3. June’s reading was the highest since April 2011 and was comfortably above the 50 level that separates growth from contraction. Read more here.





  • Autoliv enters LiDAR commercialization agreement with Velodyne. Autoliv  signed an agreement with Velodyne LiDAR, Inc. to commercialize LiDAR, a critical sensor for autonomous cars. Pursuant to the agreement, Autoliv will develop and market a scalable auto-grade LiDAR sensor using Velodyne’s core 3D software technology and proprietary LiDAR ASIC engine coupled with Autoliv‘s component development and verification capability. Read more here.

Like up on FACEBOOK


logo

Market quotes are powered by
TradingView.com



Tech Stocks ( GOOG)   (MSFT ) ( AAPL ) (BBRY ) ( gopro )  ( WDC )




INVESTORSBUZ PRESS RELEASE Valeant says plaque psoriasis drug Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that following the evaluation and approval of its Patient Access and Pricing Committee

Valeant shares jump 5% premarket on news of sale of iNova for $930 million

|Chart Calendar   | TRADE NOW | FORCAST | STOCKS

Valeant shares jump 5% premarket on news of sale of iNova for $930 million

BUZ INVESTION  Valeant shares jump 5%  Valeant Pharmaceuticals International Inc. (VRX), +8.63% said Thursday it has agreed to sell iNova Pharmaceuticals to a company owned by funds managed by private-equity firms Pacific Equity Partners and The Carlyle Group for $930 million in cash. iNova makes drugs for weight management, pain management, cardio and coughs and colds, among other things. Valeant will use the proceeds of the deal to pay down loan debt. The company is working to reduce a debt burden that stood at $26.5 billion at the end of the first quarter. The deal is expected to close in the second half.



Valeant shares jump 5%

Following through on its plan to divest certain assets to pare down debt, Valeant Pharmaceuticals (NYSE:VRX) inks an agreement with a company owned by funds managed by the Carlyle Group and Pacific Equity Partners to sell its iNova Pharmaceuticals unit for $930M in cash.

CEO Joseph Papa says, “The sale of iNova is part of the company’s ongoing efforts to both simplify our operating model and strengthen our balance sheet. We will continue to evaluate opportunities that will enable us to deliver on our commitments and unlock value for shareholders.”

The deal should close in H2.

Shares are up 5% premarket on average volume.

Business Description

Industry: Drug Manufacturers » Drug Manufacturers – Specialty & Generic    NAICS: 325412    SIC: 3741
Compare: NYSE:(TARO), NYSE:(MNK), OTCPK:(STDAF), NAS:(AKRX), NYSE:(CTLT), NAS:(OPK), NYSE:(PTHN),

OTCPK:(HKMPF), OTCPK:(HYPMY), NAS:(MDCO), NAS:(ENDP), NAS:(IRWD), OTCPK:(DNPUF),

OTCPK:(GZPHY), NYSE(:RDY), NAS:(SUPN), OTCPK:(EVTCY), NAS:(PCRX), NAS:(HZNP),

NAS:RDUS » details

Traded in other countries: VRX.CanadaBVF.GermanyVRX N.MexicoVRX.Switzerland0QYW.UK,
Headquarter Location: Canada

Valeant Pharmaceuticals International Inc is a specialty pharmaceutical and medical device company that develops, manufactures, and markets a range of generic and branded generic pharmaceuticals, over-the-counter products and medical devices.

Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia.

Like up on FACEBOOK


logo



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )




BUZ INVESTORS Google Waymo When it comes to self-driving technology, Alphabet Inc (NASDAQ:(GOOG), aka Google, is cited as the undisputed leader.

TSLA Stock: Is Google Waymo Bad News for Tesla?

Chart | Calendar   | TRADE NOW | Tesla

Could Google Waymo Hurt Tesla Stock?

BUZ INVESTORS  Google Waymo When it comes to self-driving technology, Alphabet Inc (NASDAQ:(GOOG), aka Google, is cited as the undisputed leader.

Yet, we must credit Tesla Inc (NASDAQ:(TSLA) for bringing this technology to the mainstream auto industry before Google. The reality is that the two companies are now neck-and-neck in the race. But holders of Tesla stock must be fairly cautioned that Google’s new nitrous oxide kit (read: Lyft partnership) could give it a boost past Tesla, and likely hurt TSLA stock.

To give you an idea why this matters, Tesla’s self-driving software, “Autopilot,” is a high-margin product in terms of revenue (more on this later). What this simply means is that Tesla spends little on the software and sells it for a high price. Thus, Tesla gets to keep the huge difference as profits

What Autopilot Competition Means for TESLA Stock

Coming back to Autopilot revenue, Tesla’s gross margins on this self-driving system are roughly estimated to be in excess of 90%. Yes, more than 90% of the system’s sale price is straight-up profit for Tesla. Contrast this with Tesla’s overall automotive gross margins, which stood at a little over 27% in the latest quarter.

 Google Waymo

Now, Tesla sells two types of self-driving systems. Here’s a quick look at them.

  1. The “Enhanced Autopilot” system, with limited self-driving capabilities, sells for $5,000.
  2. The “Full Self-Driving Capability,” offering complete autonomy, can be added for an additional $3,000.

So the complete package can cost buyers, who opt for it, $8,000.

Let’s say we stay conservative in our estimates and take the basic package of Enhanced Autopilot. With roughly 90% gross margins, the company is taking home a solid $4,500 in gross profit on each sale!

Why Waymo-Lyft Partnership Is Bad News for Musk’s Master Plan

Now, Google’s Waymo has just announced a new partnership with Uber Technologies, Inc.’s biggest competitor, Lyft, to make ride-sharing fully autonomous. It’s easy to predict that this will be hurting Uber.

But you may ask now why this is bad news for Tesla. To understand that, let’s revisit Tesla Chief Elon Musk’s Master Plan, Part Deux.

The second installment of Musk’s master plan includes four key goals. Two of these goals on the list are relevant here. (Source: “Master Plan, Part Deux,” Tesla Inc, July 20, 2016.)

Bottom Line on TSLA Stock

My returning readers must already know that I’m a Tesla enthusiast. This makes it incredibly difficult for me to make an anti-Tesla pitch. But, in my line of work, neutrality is both an ethical and professional requirement.

I’ll reiterate that Tesla is still early in its journey up a high growth trajectory and, thus, has a lot of room to keep growing in the coming years. Musk’s first master plan has been successful and the second master plan is nearly halfway achieved.

Business Description

Industry: Autos » Auto Manufacturers    NAICS: 336211    SIC: 3711
Compare: NYSE:(GM), NYSE:(HMC), OTCPK(:BMWYY), NYSE:(F), OTCPK:(HYMTF), OTCPK:(NSANY), OTCPK:(AUDVF), OTCPK:(RNLSY), OTCPK:(VLKAY), OTCPK:(FUJHY), OTCPK:(DDAIF), NYSE:(TTM), NYSE:(FCAU), OTCPK:(GNZUF), OTCPK:(SZKMY), OTCPK:(POAHY), OTCPK:(PUGOY), OTCPK:(BYDDF), OTCPK:(TYIDY), NYSE:(RACE) » details
Traded in other countries: TSLA34.Brazil, TL0.Germany, TSLA.Mexico, TSLA.Switzerland, 0R0X.UK,
Headquarter Location: USA

Tesla Inc is a vertically integrated sustainable energy company. It designs, develops, manufactures and sells high-performance fully electric vehicles and electric vehicle powertrain components.

Founded in 2003 and based in Palo Alto, California, Tesla is a vertically integrated sustainable energy company that also aims to transition the world to electric mobility by making electric vehicles. It sells solar panels and solar roofs for energy generation plus batteries for stationary storage for residential and commercial properties including utilities. The Tesla Roadster debuted in 2008, the S in 2012, and the X in 2015. Global deliveries in 2016 were 76,285 units. Tesla went public in 2010 and employs about 30,000 people.

Like up on FACEBOOK
 

Like up on FACEBOOK


logo

Market quotes are powered by
TradingView.com



Tech Stocks ( GOOG)   (MSFT ) ( AAPL ) (BBRY ) ( gopro )  ( WDC )

BUZ INVESTORS Cerus shares plunge Cerus Corp. (CERS), -20.33% stock plunged 16.2% to $2.52 in Tuesday morning trade after the company said it expects a supply shortage

Cerus shares plunge on news of blood-supply disruption

|Chart | Calendar   | TRADE NOW | FORCAST | STOCKS

Cerus shares plunge on news of blood-supply disruption

BUZ INVESTORS  Cerus shares plunge  Cerus Corp. (CERS), -20.33% stock plunged 16.2% to $2.52 in Tuesday morning trade after the company said it expects a supply shortage of a platelet additive solution to temporarily affect some U.S. blood centers and affect the company’s 2017 revenue. Cerus decreased its 2017 product revenue guidance from $43 million to $48 million to $38 million to $46 million accordingly. Fresenius Kabi [s:DE:FRE], the maker of the platelet additive solution, had no expected a delay in the Food and Drug Administration’s approval of a plastic component used to make the solution, Cerus said. The original piece had been discontinued by Fresenius Kabi’s supplier, Cerus said, and Fresenius Kabi is working to fix the delay and minimize supply disruption. Cerus’s Intercept blood system for platelets is used to deactivate things like viruses and bacteria in platelet components and ensure platelets’ safety; Fresenius Kabi’s Amicus platform works to separate cells and collect platelets. Availability of Fresenius Kabi’s platelet additive solution is “essential” for customers who make Intercept platelets on the Amicus platform to keep producing pathogen-reduced platelets, Cerus President William Greenman said, and the issue could affect impacted blood centers through the end of this year

Cerus shares plunge

Cerus (NASDAQ:(CERS) slips 5% premarket on modest volume in response to its announcement that it has lowered its 2017 revenue guidance to $38M – 46M from $43 – 48M.

The reason for the change is a pending shortage of Platelet Additive Solution (PAS) made and sold by Fresenius Kabi that that is expected to impact certain U.S. blood centers that produce INTERCEPT platelets. The reason for the shortage is a longer-than-expected approval by the FDA of a plastic component use in the manufacture of the PAS container following the discontinuation of the original component by Fresenius Kabi’s supplier.

In the U.S., INTERCEPT platelets can be produced in a 65/35 mixture of PAS and plasma on platelets collected on the Amicus apheresis platform.

Business Description

Industry: Biotechnology » Biotechnology    NAICS: 325414    SIC: 2834
Compare: NAS:(GLYC), NAS:(ALT), NAS:(OCUL), NAS:(CRBP), NYSE:(ZYME), NAS:(EDGE), NAS:(CNCE), OTCPK:(RCAR), NAS:(XBIT), NAS:(NVAX), NAS:(NERV), NAS:(ARDX), NAS:(ADXS), NAS:(CCXI), NAS:(NK), AMEX:(BTX), NAS:(AGEN), OTCPK:(SIGA), NAS:(VCYT), OTCPK:(NICXF) » details
Traded in other countries: CU2.Germany,
Headquarter Location: USA

Cerus Corp is a biomedical products company. It is engaged in developing and commercializing the INTERCEPT Blood System to enhance blood safety.

Cerus Corp was incorporated in California on September 19, 1991 and reincorporated in Delaware in 1996. It is a biomedical products company focused on commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System, which is based on its proprietary technology for controlling biological replication, is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion. The Company has rights for its INTERCEPT Blood System for three blood components: platelets, plasma and red blood cells. The INTERCEPT Blood System for platelets, or platelet system, and the INTERCEPT Blood System for plasma, or plasma system, have received CE marks and are being marketed and sold in a number of countries in Europe, The Commonwealth of Independent States, or CIS, the Middle East and selected countries in other regions around the world. The Company sells both the platelet and plasma systems using its direct sales force and through distributors. Company continue to use, third parties to manufacture and supply the devices, disposable kits and inactivation compounds that make up the INTERCEPT Blood System for use in clinical trials and for commercialization. The Company owns approximately 12 issued or allowed United States patents and approximately 87 issued or allowed foreign patents related to the INTERCEPT Blood System. The market for the INTERCEPT Blood System is subjected by a relatively small number of blood collection organizations. Many of these organizations are national blood transfusion services or Red Cross organizations who collect, store and distribute virtually all of their respective nations’ blood and blood component supplies. The European markets for its products are in Germany, France, and England. The Company and its products are comprehensively regulated in the United States by the FDA and, in some instances, by state and local governments, and by comparable governmental authorities in other countries.
Like up on FACEBOOK


logo



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )

BUZ INVESTORS Market Open U.S. missile attack on Syria puts markets on edge. The order of the missile attack on Syria

Top News Before the Market Opens

Top News Before the Market Opens

Top News Before the Market Opens

BUZ INVESTORS  TOP NEWS

  • WannaCry puts focus on cybersecurity stocks. Security officials are scrambling to find out who was behind the WannaCry ransomware attack, which struck 200K victims in at least 150 countries, and is believed to have been stolen from the NSA. Shares of cybersecurity stocks are on watch amid fears a second wave could cause more chaos, while (MSFT) pinned blame on the U.S. government for not disclosing more software vulnerabilities. Read more here.

  • Saudi Arabia, Russia push to extend oil output cuts until March 2018. Oil prices rose 2% after Saudi Arabia and Russia, the world’s top two producers, said that a crude production cut would be extended from the middle of this year until March 2018.While the output cut will initially be on the same volume terms as before, they hope other producers will join in their efforts. OPEC is due to meet in Vienna on May 25. Read more here.

  • Google unveils new ad policies. Google is changing how it enforces it ads policies: It will now strike ads from individual web pages that violate its ads standards. That means (GOOG) will effectively be cutting fewer websites out of its ad network. Entire sites may still be suspended on the AdSense platform for violations, and publishers can also still be suspended or disabled from using AdSense. Read more here.

  • Intel and Samsung back FTC lawsuit against Qualcomm. FTC kicked off 2017 by targeting Qualcomm over allegedly anti-competitive behavior, and unsurprisingly, companies the chipmaker competes with agree. (INTC) and (SSNLF)
    have filed briefs supporting the agency’s lawsuit, claiming (QCOM) uses its dominant position in the mobile processor industry to squeeze others out and force customers to accept unfair terms. Read more here.

  • Lyft and Waymo reach deal to collaborate on self-driving cars. The two confirmed that they would work together on pilot projects and product development to bring autonomous driving into the mainstream. Other details are hard to come by, though. The deal makes Waymo a( GM) partner, by way of (Lyft)’s work with (and investment by) the auto giant. Lyft and GM are set to publicly test autonomous Chevy Bolts on Lyft’s network in the next few years. Read more here.




TOP NEWS

>>>TRADE NOW<<<

 

Futures of U.S. major indices
DJIA 20867.00 (+0.09%)
S&P500 2389.00 (+0.01%)
Nasdaq 100 5684.38 (-0.08%)


Pre-Market Top Gainers                      Pre-Market Top Losers

Kemet +3.28%                                        Mazor Robotics -4.28%
Chesapeake Energy +3.20%                  Stratasys -2.84%
Tenaris +3.12%                                       Tesla -2.68%
FireEye +3.04%                                      Trade Desk -2.22%
Masimo +2.56%                                      Paychex -1.60%


Pre-Market Most Active Stocks (By Volume)

HSBC Holdings 32.80K
Rio Tinto 20.60K
SAP 11.10K
Tesla 10.72K
Telefonica 10.70K

Like up on FACEBOOK


logo

Market quotes are powered by
TradingView.com



Tech Stocks ( GOOG)   (MSFT ) ( AAPL ) (BBRY ) ( gopro )  ( WDC )




BUZ INVESTORS Market Open U.S. missile attack on Syria puts markets on edge. The order of the missile attack on Syria

Top News Before the Market Opens

|Chart | Calendar   | TRADE NOW | FORCAST | STOCKS

Top News Before the Market Opens

Top News Before the Market Opens

BUZ INVESTORS OPEN MARKET

  • On Thursday the Dow Index logged its 3rd consecutive down day as Microsoft, Home Depot and Wal-Mart all posted drops of over 1%. The focus of investors seemed to be on corporate news as opposed to the headlines out of D.C. A 17% drop by Macy’s and the 21% plunge for Snap resonated across the retail and tech sectors, respectively. The DJIA ended down 0.1%, while both the S&P 500 Index and Nasdaq Composite Index fell 0.2%. Read more here.

  • WSJ: U.S., China reach deal to expand U.S. exports including LNG. The U.S. and China have reached agreement on broad terms to grant U.S. natural gas exporters and certain other industries easier access to Chinese markets, WSJ reports. The exact provisions on gas exports are unclear, but will call for opening Chinese gas markets and joint investment in infrastructure projects in China needed to process and import LNG, according to the report. Read more here.

  • Petrobras posts biggest profit in 2 years. Brazilian state-controlled oil company Petróleo Brasileiro SA reported its largest quarterly earnings in 2 years Thursday as crude prices rose and the government allowed it to sell fuel at a profit in the domestic market. A rise in crude prices relieved pressure for government subsidy. Net finance expense was $2.465B; the company managed to reduce total debt to $115.1B from last quarter’s $118.4B. Read more here.

  • Wells Fargo sees mortgage deal return. Wells Fargo is hoping this year to sell MBSs without government guarantees for the first time since the financial crisis, according to the head of the bank’s consumer lending division. Read more here.

  • German Q1 GDP growth beats U.S. Germany’s economy accelerated in the first quarter, with GDP growing at a quarterly clip of 0.6%, or 2.4% in annualized terms. That means the U.K., Japan, France and Italy all recorded lower growth rates than in Q1. Read more here.

Futures of U.S. major indices
DJIA 20833.00 (-0.18%)
S&P500 2385.25 (-0.24%)
Nasdaq 100 5659.75 (-0.19%)





OPEN MARKET

>>>TRADE NOW<<<

Pre-Market Top Gainers                      Pre-Market Top Losers

Trade Desk +24.09%                            ArcelorMittal -4.25%
AstraZeneca +4.40%                            3D Systems -3.50%
Eldorado Corp +3.54%                         Euronav -1.85%
Sprint +3.18%                                       Yandex -1.30%
Twillio +2.27%                                      General Electric -1.28%


Pre-Market Most Active Stocks (By Volume)

Telefonica 82.60K
Aegon 48.85K
Fiat Chrysler 19.97K
3D Systems 15.97K
Apple 15.69K




BUZ INVESTORS Market Open U.S. missile attack on Syria puts markets on edge. The order of the missile attack on Syria

Top News Before the Market Opens

Top News Before the Market Opens

Top News Before the Market Opens

BUZ INVESTORS MARKET OPEN

  • Snap shares plunge after ugly earnings. Snapchat owner reported slowing user growth and revenue in its first earnings report as a public company, missing some Wall Street estimates. Snap said its daily active users (DAUs) rose 36.1% to 166M in the 1st quarter from a year earlier, marking a slowdown from the 47.7% rise for the 4th quarter and 62.8% jump for the 3rd quarter that the company reported in its IPO filing. The tech company’s net loss widened to $2.21B, or $2.31 per share, in the first quarter, from $104.6M, or 14 cents per share, due to stock-based compensation related to the IPO. Read more here.
  • Straight Path plunges 20% after AT&T pulls out of bidding. It’s official now: Verizon will buy Straight Path for $184 per share in an all-stock deal. AT&T will receive a $38M termination fee. The price represents a 404% premium to the close on April 7 – the day before the announcement of the AT&T agreement, but is substantially less than STRP’s close last night of $223.79. Read more here.
  • Bitcoin crosses $1,800 as monster rally continues. Bitcoin cleared the $1,800-level for the first time on Thursday to hit a fresh record high, as a month-long monster rally continues amid bullish noises around the future of the cryptocurrency. Prices rose to a daily peak of $1,839.23. It was last at $1,817.42 a coin, up around 3.5%. It rose more than $100 in just two days, after clearing $1,700 for the first time on Tuesday. The digital currency has gained for 18 straight days, rising almost 50% over that time. Since the start of the year, the price of bitcoin has soared 81%. Read more here.
  • Moody’s cuts credit ratings of six Canadian banks. Noting continuing growth in Canadian consumer debt and bubbly housing prices leave that country’s banks vulnerable to potential losses, Moody’s downgraded the credit ratings of TD Bank, Bank of Montreal, Scotiabank, CIBC, RBC, and National Bank of Canada. Read more here.
  • Macy’s falls as weak sales trend continues. Macy’s reported that comparable sales fell 4.6% on an owned plus licensed basis in Q1, which missed the consensus estimate for a 3.5% decline. Macy’s expects sales to fall 3.2% to 4.3% in FY17 and EPS to land in a range of $3.37 to $3.62. Read more here.




MARKET OPEN

>>>TRADE NOW<<<

Futures of U.S. major indices
DJIA 20866.00 (-0.13%)
S&P500 2390.75 (-0.19%)
Nasdaq 100 5662.88 (-0.22%)Pre-Market Top Gainers                      Pre-Market Top Losers

Sangamo Biosciences +43.68%           Snap -22.85%
TerraVia Holdings +7.77%                    Santander Mexico -20.74%
Himax +7.74%                                      Conatus Pharma -18.66%
Iconix Brand Group +5.67%                 MannKind -17.50%
Denbury Resources +5.26%                Macy’s -10.53%

Like up on FACEBOOK


logo

Market quotes are powered by
TradingView.com



Tech Stocks ( GOOG)   (MSFT ) ( AAPL ) (BBRY ) ( gopro )  ( WDC )




BUZ INVESTORS Stocks finished quarter with solid gains U.S. stocks closed lower on Friday, but still posted sizable weekly and quarterly gains.

Top News Before the Market Opens

Top News Before the Market Opens

Top News Before the Market Opens

BUZ INVESTORS  TOP NEWS

  • NVIDIA stock rockets up after earnings beat. The company reported $0.79 EPS on $1.94B in revenue, beating consensus of $0.66 EPS on $1.91B in revenue. More importantly, NVIDIA’s revenue was up 48% Y/Y while GAAP EPS was up 126% Y/Y. NVIDIA also gave very strong guidance for the 2nd quarter, calling for $1.89B to $1.95B in revenue. NVIDIA was particularly bullish on its data center GPU business and its prospects in artificial intelligence. Read more here.

  • ESPN concerns drag on Disney, shares dip. Walt Disney appears set to weigh on the Dow as a decline in subscribers and higher programming costs at cash-cow ESPN caused the entertainment giant’s revenues to miss consensus. Iger said Disney was adapting quickly to the changing TV marketplace and was encouraged by consumer interest in digital services that feature ESPN. Read more here.

  • President Trump fires FBI Director James Comey. Gold prices were higher on Wednesday, bouncing off the prior session’s eight-week low after U.S. President Donald Trump abruptly fired FBI Director James Comey in a move that shocked Washington. Market analysts are warning that Comey’s firing could create a sideshow that may delay the Trump Administration’s plans on tax reform and infrastructure spending, while some experts are suggesting investors were spooked by yet another example of Trump’s unpredictable behavior which puts markets on edge. Read more here.

  • Snap’s first earnings report since its IPO will be released after the bell. Snap Inc. will likely use the opportunity to show that it can grow its user base and ad money, but the competition is quickly heating up, with Facebook copying similar offerings and functions on its platform. Snap’s stock has also been on a roller-coaster ride for the last couple of months, following its blockbuster IPO on March 2. Read more here.

  • Microsoft patents “Shazam for food”. Microsoft has been granted a patent for augmented reality headwear that can monitor what one eats, warn about calorie content and makes food recommendations based on nutritional needs. It might also be used to help guide decisions around food preparation, shopping and choosing restaurants. Read more here.




TOP NEWS

>>>TRADE NOW<<<

Futures of U.S. major indices
DJIA 20874.00 (-0.16%)
S&P500 2391.25 (-0.08%)
Nasdaq 100 5675.38 (-0.02%)


Pre-Market Top Gainers                     Pre-Market Top Losers

Argos Therapeutics +24.39%               Yelp -22.96%
MannKind +16.07%                              Fossil -18.84%
NVIDIA +12.93%                                  FuelCell Energy -14.31%
Crocs +12.90%                                     Depomed -13.78%
Walter Investment +12.07%                 Acacia Communications -10.66%


Pre-Market Most Active Stocks (By Volume)

West Corp. 7.96M
Yelp 1.43M
NVIDIA 1.13M
AU Optronics 1.04M
Mylan 618.90K

Like up on FACEBOOK


logo

Market quotes are powered by
TradingView.com



Tech Stocks ( GOOG)   (MSFT ) ( AAPL ) (BBRY ) ( gopro )  ( WDC )